Earnings Preview: Albemarle (ALB) Q2 Earnings Expected to Decline

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Albemarle due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2] Earnings Expectations - Albemarle is expected to report a quarterly loss of $0.83 per share, reflecting a significant year-over-year change of -2175% [3] - Revenue projections stand at $1.24 billion, indicating a decrease of 13.1% from the previous year [3] Estimate Revisions - The consensus EPS estimate has been revised down by 36.03% over the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate for Albemarle is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +21.13% [12] Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive Earnings ESP reading is a strong predictor of an earnings beat, particularly when combined with a favorable Zacks Rank [10] - Albemarle currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat despite the positive Earnings ESP [12] Historical Performance - In the last reported quarter, Albemarle was expected to post a loss of $0.62 per share but actually reported a loss of -$0.18, resulting in a surprise of +70.97% [13] - Over the past four quarters, Albemarle has only beaten consensus EPS estimates once [14] Industry Context - Another company in the Zacks Chemical - Diversified industry, Olin, is expected to report earnings of $0 per share, reflecting a year-over-year change of -100% [18] - Olin's revenue is projected at $1.67 billion, which is a slight increase of 1.5% from the previous year [18] - Olin's consensus EPS estimate has been revised down by 24% over the last 30 days, and it currently has an Earnings ESP of -869.36% [19][20]